Since 2012, multiple groups using various techniques published the rearrangement of RET in NSCLC with four identified fusion partners so far (KIF5B- CCDC6-, NOCA4-, TRIM33-) (2) (Table 1). Here, RET is linked to non-small cell lung carcinoma.